For over three decades, the Rivkin Center has set the gold standard in ovarian cancer research funding, using NIH-recognized processes to award grants. Our impact is measured not just in numbers, but in lives transformed and hope restored, with significant advancements benefiting both the scientific community and those affected by the disease.
The Rivkin Center's strategic investments in ovarian cancer research have produced remarkable returns. For every $1 invested, awardees on average secure another $17.3 to continue their research
Pilot Study Awards allow promising ideas to be tested and proven worthy of further investigation.
$75k Pilot Study Award to Dr. Steffan Nawrocki led to a $1.2M grant from Takeda Pharmaceuticals.
Scientific Scholar Awards nurture young, talented investigators, ensuring the future of ovarian cancer research.
After receiving a $120k Scientific Scholar Award in 2021, Dr. Naoko Sasamoto of Harvard University has already published seven manuscripts, won an Early Career Investigator Award, and secured two large-scale grants.
Bridge Funding Awards help promising researchers gather the final data needed to secure federal grants.
$30k Bridge Funding grant led to ~$1.76M in National Institutes of Health (NIH) funding, representing a 59X return on investment.
Through a pioneering public-private partnership with Washington state’s Andy Hill Cancer Research Endowment (CARE) Fund, we are jointly investing $1M in ovarian cancer research over two years. This collaboration aims to catalyze innovation and drive advancements in early detection and treatments, benefiting patients across Washington state and beyond. It also promises to be a model for other states to follow to increase investments in cancer research.
The Rivkin Center hosts pivotal symposia that are crucial to advancing the fight against ovarian cancer. The Biennial Ovarian Cancer Research Symposium and the Northwest Gynecological Cancer Symposium (NGCS) play a key role in fostering collaboration and innovation within the scientific community.
Biennial Ovarian Cancer Research Symposium
This symposium is the largest and longest-standing ovarian cancer conference globally, co-produced with the American Association for Cancer Research (AACR). It provides a platform for scientists and clinicians worldwide to share the latest advancements, helping to accelerate progress toward effective treatments and early detection strategies.
Northwest Gynecological Cancer Symposium (NGCS)
Focusing on regional collaboration, the NGCS facilitates communication and cooperation among researchers and clinicians in the Pacific Northwest. The symposium provides an invaluable platform for younger researchers in the region's top cancer research labs to connect with and present their work to veteran researchers, fostering collaboration and mentoring opportunities.
Community engagement is essential to our mission. Events like Science for Dinner, SummeRun, and the Giving Gala bring together survivors, supporters, researchers, and advocates. These gatherings not only raise essential funds but also foster a sense of solidarity and collective action. Every contribution and every story shared strengthens our resolve to create a future free from ovarian cancer.